Lung Cancer Awareness: Know the Signs, Understand Your Risk and Explore Treatment Options
Lung cancer awareness is important for understanding the risks, recognizing potential symptoms and learning about advances in diagnosis and treatment. Lung cancer is one of the most commonly diagnosed cancers in the United States and remains a leading cause of cancer-related deaths. However, advances in cancer research continue to provide patients with new treatment options and opportunities for personalized care.
Although smoking is the leading risk factor for lung cancer, people who have never smoked can develop lung cancer, too. Understanding your risk, knowing the warning signs and talking with your healthcare provider about screening when appropriate can help you take an active role in your health.
At Tennessee Cancer Specialists, our team provides personalized oncology care for patients throughout Northeast Tennessee, with locations in Johnson City, Kingsport and Greeneville. Our goal is to help patients understand their diagnosis, explore treatment options and receive compassionate support throughout their cancer journey.
What Is Lung Cancer?
Lung cancer develops when abnormal cells in the lungs grow uncontrollably. These cells can form tumors, interfere with normal lung function and potentially spread to other parts of the body.
There are two primary types of lung cancer:
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It includes several subtypes, such as adenocarcinoma, squamous cell carcinoma and large cell carcinoma.
Treatment depends on the specific subtype, stage of the cancer and other characteristics, including certain genetic changes that may influence treatment decisions.
Small Cell Lung Cancer
Small cell lung cancer (SCLC) is less common but tends to grow and spread more quickly than non-small cell lung cancer.
Treatment often involves chemotherapy, immunotherapy, radiation therapy or a combination of approaches, depending on the extent of the disease and the patient’s individual circumstances.
Identifying the type of lung cancer is an important step in determining the most appropriate treatment plan.
What Are the Symptoms of Lung Cancer?
Lung cancer does not always cause noticeable symptoms in its early stages. When symptoms develop, they may resemble those of other respiratory conditions.
Potential lung cancer symptoms include:
- A persistent cough that does not improve or gets worse
- Coughing up blood or rust-colored sputum
- Chest pain or discomfort
- Shortness of breath
- Wheezing
- Hoarseness
- Frequent respiratory infections, such as bronchitis or pneumonia
- Unexplained weight loss
- Persistent fatigue
- Loss of appetite
These symptoms do not necessarily indicate lung cancer, as many other conditions can cause similar problems. However, persistent, worsening or unexplained symptoms should be evaluated by a healthcare provider.
Do not wait for symptoms to become severe before seeking medical advice.
Understanding Lung Cancer Risk Factors
Several factors can increase the risk of developing lung cancer. While some risks can be reduced, others are related to environmental exposures or personal medical history.
Smoking and Tobacco Use
Smoking is the leading cause of lung cancer. Cigarette smoke contains chemicals that can damage lung cells and contribute to cancer development.
The risk of lung cancer increases with the amount and duration of smoking. Quitting smoking can reduce risk over time, even for people who have smoked for many years.
Exposure to secondhand smoke can also increase lung cancer risk.
Radon Exposure
Radon is a naturally occurring radioactive gas that can accumulate inside homes and buildings. Long-term exposure to elevated radon levels is a significant cause of lung cancer, particularly among people who smoke.
Testing your home for radon can help identify elevated levels and determine whether corrective measures are needed.
Workplace and Environmental Exposures
Exposure to certain substances may increase lung cancer risk. These include asbestos, arsenic, diesel exhaust and other hazardous materials.
People who work in industries involving these substances may benefit from understanding their exposure history and discussing any concerns with their healthcare provider.
Family History
Having a close relative who has had lung cancer may be associated with an increased risk. Family history can reflect a combination of inherited factors and shared environmental exposures.
Previous Radiation Therapy
People who have received radiation therapy to the chest for another cancer may have an increased risk of developing lung cancer later in life.
Can Lung Cancer Develop in People Who Never Smoked?
Yes. Although smoking is the leading risk factor, lung cancer also occurs in people who have never smoked.
Other factors, including radon exposure, secondhand smoke, environmental exposures and certain genetic changes, may contribute to lung cancer in people who have never used tobacco.
This is why persistent respiratory symptoms should not automatically be dismissed based on smoking history alone.
What Is Lung Cancer Screening?
Lung cancer screening can help detect lung cancer before symptoms develop. For eligible individuals, screening may identify cancer at an earlier stage, when treatment may offer better outcomes.
The recommended screening method is a low-dose computed tomography scan, commonly called a low-dose CT scan or LDCT.
Unlike a standard chest X-ray, a low-dose CT scan produces detailed images of the lungs and can identify small abnormalities that may require further evaluation.
Who Should Consider Lung Cancer Screening?
In the United States, the U.S. Preventive Services Task Force recommends annual lung cancer screening with low-dose CT for adults who:
- Are ages 50 through 80
- Have a smoking history of at least 20 pack-years
- Currently smoke or quit within the past 15 years
A pack-year is calculated by multiplying the average number of packs smoked per day by the number of years a person smoked. For example, smoking one pack daily for 20 years equals 20 pack-years.
Screening recommendations may differ depending on individual circumstances and other professional guidelines. Screening is generally discontinued when a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to undergo curative lung surgery.
Talk with your healthcare provider to determine whether lung cancer screening is appropriate for you.
It is also important to understand that screening is intended for eligible people who do not have symptoms. Anyone experiencing concerning symptoms may need diagnostic testing regardless of whether they meet screening criteria.
How Is Lung Cancer Diagnosed?
If a screening test or other examination identifies a suspicious lung abnormality, additional testing may be necessary.
Depending on the situation, diagnostic evaluation may include:
- CT scans or PET scans
- Bronchoscopy to examine the airways
- Needle biopsy or another tissue sampling procedure
- Laboratory examination of tissue samples
- Molecular and genetic testing
A biopsy can help confirm whether cancer is present and identify the specific type of lung cancer.
For some patients, molecular testing can identify genetic changes in cancer cells that may help guide treatment. Understanding the cancer’s stage and characteristics is essential for developing an individualized treatment plan.
Lung Cancer Treatment Options
Lung cancer treatment has advanced significantly in recent years. The most appropriate approach depends on the type and stage of cancer, molecular characteristics, overall health and individual treatment goals.
Depending on the diagnosis, treatment may include the following.
Surgery
Surgery may be an option for certain patients with early-stage lung cancer. The goal is to remove the tumor and surrounding tissue as appropriate.
Radiation Therapy
Radiation therapy uses high-energy radiation to destroy cancer cells. It may be used alone or alongside other treatments, depending on the type and stage of lung cancer.
Chemotherapy
Chemotherapy uses medications to destroy cancer cells or slow their growth. It may be used before or after surgery, combined with radiation or as part of treatment for more advanced disease.
Targeted Therapy
Targeted therapies are designed to act on specific genetic changes or proteins that help cancer cells grow.
For certain lung cancers, molecular testing can identify changes that may make targeted medications an option.
Immunotherapy
Immunotherapy helps the immune system recognize and attack cancer cells. It has become an important treatment option for certain types and stages of lung cancer.
Clinical Trials
Clinical trials evaluate new cancer treatments and combinations of existing therapies. Eligible patients may have opportunities to participate in research that could expand future treatment options.
Not every treatment is appropriate for every patient. An individualized evaluation helps determine which approaches may provide the greatest benefit.
The Importance of Personalized Lung Cancer Care
A lung cancer diagnosis can bring uncertainty and many questions about treatment, side effects, prognosis and what comes next.
At Tennessee Cancer Specialists, we understand that each patient’s experience is different. Treatment decisions depend on the specific cancer diagnosis, stage, molecular characteristics, overall health and individual needs.
Our oncology team works with patients to explain their options and develop personalized treatment plans. We are committed to providing comprehensive cancer care and compassionate support throughout the treatment journey.
Lung Cancer Clinical Trials and Research
Ongoing research is helping physicians better understand lung cancer and develop more effective treatments.
For eligible patients, clinical trials may provide access to investigational therapies, new medication combinations or emerging approaches to cancer care.
Tennessee Cancer Specialists offers clinical trials through the Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations.
Clinical trials are not suitable for every patient, but your oncology team can help determine whether a study may be an option based on your diagnosis, previous treatments and individual circumstances.
What Can You Do During Lung Cancer Awareness Month?
Lung cancer awareness is about more than recognizing the disease. It is an opportunity to take practical steps toward protecting your health and encouraging others to do the same.
Consider these steps:
- Talk with your healthcare provider about your personal lung cancer risk.
- Ask whether you qualify for annual low-dose CT screening.
- Avoid smoking and seek support if you want to quit.
- Test your home for radon.
- Discuss persistent respiratory symptoms with a healthcare professional.
- Learn about lung cancer treatment advances and clinical research.
- Encourage friends and family members to learn about screening eligibility.
Although lung cancer cannot always be prevented, understanding risk factors and taking appropriate preventive steps can make a meaningful difference.
Lung Cancer Care Throughout East Tennessee
If you or someone you love has been diagnosed with lung cancer, having a knowledgeable oncology team can help you better understand your diagnosis and treatment options.
Tennessee Cancer Specialists provides personalized oncology and hematology care throughout East Tennessee, with eight full-time office locations and additional satellite offices to help patients access cancer care closer to home.
Our full-time offices are located in:
- Knoxville: Dowell Springs and Parkwest
- Greeneville
- Johnson City
- Kingsport
- Morristown
- Powell
- Harrogate
Our satellite offices serve patients in:
- Athens
- Downtown Regional in Knoxville
- Jefferson City Memorial Hospital
- Jefferson City–Summit
- LaFollette
- Newport
- Oak Ridge
- Sweetwater
- Turkey Creek in Knoxville
Satellite office schedules vary by location. Visit the Tennessee Cancer Specialists locations page for addresses, contact information and current office details.
Our team is committed to helping patients navigate a lung cancer diagnosis with individualized treatment planning, compassionate support and access to clinical research when appropriate. Through our clinical research partnership with the Sarah Cannon Research Institute (SCRI), eligible patients may also have opportunities to explore clinical trials.
This lung cancer awareness season, take time to learn the warning signs, understand your risk and talk with your healthcare provider about screening when appropriate.
Knowing the signs, understanding your risk and learning about available treatment options are important steps in the lung cancer journey.